Evidence map›Paper›PMID 28854284›Full record

SynthesisPloS one2017

D-galactose-induced brain ageing model: A systematic review and meta-analysis on cognitive outcomes and oxidative stress indices.

Saeed Sadigh-Eteghad, Alireza Majdi, Sarah K McCann, Javad Mahmoudi, Manouchehr S Vafaee, Malcolm R Macleod

Erratum issuedOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Protective effects ofBiomedical reports · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Frontiers in medicine · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Saeed Sadigh-EteghadNeurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran.
Alireza MajdiNeurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0002-2990-4762
Sarah K McCannCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland, United Kingdom.
Javad MahmoudiNeurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran.
Manouchehr S VafaeeDepartment of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Malcolm R MacleodDepartment of Clinical Neurosciences, The University of Edinburgh, Edinburgh, United Kingdom.
Tabriz University of Medical Sciences · IRUniversity of Edinburgh · GBUniversity of Copenhagen · DK

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/L000970/1
6 · The paper itself

Abstract

Animal models are commonly used in brain ageing research. Amongst these, models where rodents are exposed to d-galactose are held to recapitulate a number of features of ageing including neurobehavioral and neurochemical changes. However, results from animal studies are often inconsistent. To better understand the characteristics of the model and effects of d-galactose on neurobehavioral and neurochemical outcomes in rodents we performed a systematic review and meta-analysis. We applied random-effects meta-analysis to evaluate the effect of study features. Our results give an overview of the characteristics of the d-galactose rodent ageing model, including neurobehavioral and neurochemical outcomes. We found that few studies took measures to reduce risks of bias, and substantial heterogeneity in the reported effects of d-galactose in included studies. This highlights the need for improvements in the use of the d-galactose rodent ageing model if it is to provide useful in the development of drugs to treat human ageing.

Indexed as

AgingAnimalsBrainCognitionCognition DisordersGalactoseHumansModels, AnimalOxidative StressGalactose

Identifiers

PMID28854284
PMCPMC5576729
OpenAlexW2753824094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.